Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 86601-86650 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05376423
To Evaluate OBI-833/OBI-821 in Patients With Locally Advanced, Globo H-Positive Esophageal Cancer for Recurrence
PHASE2Recruiting
60 participants
Started: Jun 2, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05243862
Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.
PHASE2Active, not recruiting
18 participants
Started: Jun 2, 2022 · Completed: Jun 2, 2026
1 condition3 sponsors3 locations
NCT05268094
Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)
NARecruiting
300 participants
Started: Jun 2, 2022 · Completed: Apr 1, 2027
1 condition2 sponsors24 locations
NCT05321875
Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)
PHASE3Recruiting
320 participants
Started: Jun 2, 2022 · Completed: Jun 2, 2026
1 condition1 sponsor1 location
NCT05195632
Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer
PHASE2Active, not recruiting
63 participants
Started: Jun 2, 2022 · Completed: Sep 5, 2026
1 condition1 sponsor34 locations
NCT05282485
Mitigating Infectious Morbidity and Growth Deficits in HIV Exposed Uninfected infanTs With Human Milk Oligosaccharides
NAActive, not recruiting
140 participants
Started: Jun 2, 2022 · Completed: Sep 10, 2027
3 conditions5 sponsors1 location
NCT05417906
Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations
PHASE2Active, not recruiting
110 participants
Started: Jun 2, 2022 · Completed: Sep 30, 2026
2 conditions2 sponsors2 locations
NCT05357313
Adjunctive Bright Light Therapy in Patients With Bipolar Depression and Eveningness
NARecruiting
70 participants
Started: Jun 2, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05528354
Venetoclax and Decitabin Based Conditioning Regimen Followed With Post-HSCT Decitabin Maintenance Therapy in TP53 Mutant AML/MDS Patients
EARLY_PHASE1Recruiting
58 participants
Started: Jun 2, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06158789
Repetitive Blood Brain Barrier Opening for Alzheimer's Disease.
NAActive, not recruiting
6 participants
Started: Jun 2, 2022 · Completed: Jan 19, 2024
1 condition2 sponsors1 location
NCT03856515
Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes
NAActive, not recruiting
169 participants
Started: Jun 2, 2022 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT05204147
Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers
PHASE1Recruiting
20 participants
Started: Jun 2, 2022 · Completed: Jul 21, 2026
2 conditions2 sponsors1 location
NCT05367440
Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer
PHASE1/PHASE2Recruiting
175 participants
Started: Jun 2, 2022 · Completed: Apr 17, 2031
1 condition2 sponsors27 locations
NCT05276310
A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy
PHASE1Recruiting
62 participants
Started: Jun 2, 2022 · Completed: Aug 30, 2029
1 condition1 sponsor3 locations
NCT05409261
Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine
PHASE2Active, not recruiting
200 participants
Started: Jun 2, 2022 · Completed: Mar 31, 2025
4 conditions6 sponsors1 location
NCT05819463
Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland
N/ARecruiting
700 participants
Started: Jun 2, 2022 · Completed: Dec 31, 2032
1 condition1 sponsor9 locations
NCT05234866
Paradoxical Lucidity in Severe End-Stage Dementia
N/ARecruiting
520 participants
Started: Jun 2, 2022 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT05115110
A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy
PHASE2/PHASE3Active, not recruiting
259 participants
Started: Jun 2, 2022 · Completed: Feb 27, 2029
1 condition1 sponsor35 locations
NCT04755205
A Natural History Study of Children and Adults With Olfactory Neuroblastoma
N/ARecruiting
525 participants
Started: Jun 2, 2022 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT05428969
A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies
PHASE1/PHASE2Active, not recruiting
181 participants
Started: Jun 2, 2022 · Completed: Apr 30, 2026
4 conditions1 sponsor10 locations
NCT05608603
Diagnostics of Coronavirus Disease 2019 Cardiovascular Complications
N/AEnrolling by invitation
100 participants
Started: Jun 2, 2022 · Completed: Nov 30, 2025
6 conditions1 sponsor1 location
NCT05239624
Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
PHASE2Recruiting
23 participants
Started: Jun 2, 2022 · Completed: Jun 30, 2026
1 condition4 sponsors10 locations
NCT05112601
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
PHASE2Recruiting
81 participants
Started: Jun 2, 2022 · Completed: Apr 30, 2026
9 conditions2 sponsors111 locations
NCT06272669
Cumulative and Booster Effects of Multisession Prefrontal TDCS in ASD Adolescents
NARecruiting
90 participants
Started: Jun 2, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05652062
Prizvalve® Transcatheter Valve-in-Valve Implantation Exploratory Study
NARecruiting
5 participants
Started: Jun 2, 2022 · Completed: Jun 2, 2024
1 condition2 sponsors1 location
NCT05252078
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
PHASE2Recruiting
30 participants
Started: Jun 2, 2022 · Completed: Nov 30, 2026
11 conditions2 sponsors1 location
NCT05454787
Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)
N/ARecruiting
300 participants
Started: Jun 2, 2022 · Completed: Nov 30, 2025
2 conditions1 sponsor89 locations
NCT05414253
Evaluation of Chlorhexidine Plus Hyaluronic Acid Mouthwash in Surgical Wound Healing Following Third Molar Surgery (CLOR_4)
NARecruiting
54 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT07029841
Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong
N/ARecruiting
1,000 participants
Started: Jun 1, 2022 · Completed: Dec 30, 2032
3 conditions2 sponsors1 location
NCT04797481
Pilot Testing of an Online Rehabilitation Intervention for People With Heart Failure (PORIAS-HF).
NAEnrolling by invitation
40 participants
Started: Jun 1, 2022 · Completed: Jul 30, 2025
1 condition3 sponsors1 location
NCT06500767
Psycho-emotional Impact of Preoperative Counselling in Cervico-carcinoma Screening Programs
N/ARecruiting
300 participants
Started: Jun 1, 2022 · Completed: Jul 31, 2025
3 conditions1 sponsor1 location
NCT05524649
Effect of Probiotics on Infant's Fecal Microbiota Composition
NARecruiting
120 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT04397159
Effects of Combination Exercise on Fatigability in Veterans With Chronic Kidney Disease
NARecruiting
30 participants
Started: Jun 1, 2022 · Completed: Apr 1, 2026
1 condition1 sponsor1 location
NCT05566002
Artificial Intelligence-assisted Evaluation of Pulmonary HYpertension
N/ARecruiting
2,000 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05347641
Penpulimab Combined With RMA Treatment of Primary Diagnosis of Primary Central Nervous System Lymphoma
PHASE2Not yet recruiting
23 participants
Started: Jun 1, 2022 · Completed: Jun 1, 2029
1 condition1 sponsor0 locations
NCT05400239
SOTO: Treatment Sensitivity of Organoids to Predict Treatment Outcome
N/ARecruiting
60 participants
Started: Jun 1, 2022 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT05792202
Combined Microfracture Procedure Promotes Tendon Healing
NARecruiting
50 participants
Started: Jun 1, 2022 · Completed: Jun 1, 2026
3 conditions1 sponsor1 location
NCT05991167
"EndeavorRx® Prospective Product Registry (Expedition EndeavorRx)"
N/AActive, not recruiting
150 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05361161
Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC)
PHASE2Not yet recruiting
60 participants
Started: Jun 1, 2022 · Completed: Dec 1, 2025
2 conditions1 sponsor0 locations
NCT06177210
Type 2 Diabetes Remission
N/AActive, not recruiting
20 participants
Started: Jun 1, 2022 · Completed: Aug 30, 2025
1 condition2 sponsors1 location
NCT05409352
Self-administered Acupressure to Improve Cancer-related Fatigue Among Cancer Patients Undergoing Chemotherapy
NARecruiting
138 participants
Started: Jun 1, 2022 · Completed: May 31, 2025
4 conditions1 sponsor1 location
NCT05518331
The Safety and Efficacy Study of Avatrombopag Switch in TPO-RA Refractory AA
NARecruiting
39 participants
Started: Jun 1, 2022 · Completed: Jan 1, 2026
1 condition6 sponsors1 location
NCT05441696
Study for the Evaluation of a Non-invasive Hemodynamic Measurement in Heart Failure Patients
N/AEnrolling by invitation
65 participants
Started: Jun 1, 2022 · Completed: Sep 29, 2026
1 condition1 sponsor2 locations
NCT05075161
Pirfenidone to Prevent Fibrosis in Ards.
PHASE3Recruiting
130 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor17 locations
NCT04808206
A Registry of Laparoscopic Bariatric Surgery Using Stapling Devices: Observation of Safety and Clinical Efficacy
N/AActive, not recruiting
150 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor3 locations
NCT05062915
Diagnostic Work up and Management of Acute Onset Vertigo
NAActive, not recruiting
90 participants
Started: Jun 1, 2022 · Completed: Jul 1, 2025
2 conditions1 sponsor1 location
NCT05361772
Low-dose Colchicine Inhibit Abdominal Aortic Aneurysm Growth Trial
NANot yet recruiting
230 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
3 conditions8 sponsors0 locations
NCT05216185
The Assessment of Bone Health in a Clinical Setting
N/ANot yet recruiting
5,000 participants
Started: Jun 1, 2022 · Completed: Feb 28, 2027
1 condition1 sponsor0 locations
NCT07032103
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV
N/ARecruiting
2,000 participants
Started: Jun 1, 2022 · Completed: Dec 30, 2028
1 condition1 sponsor1 location
NCT05426616
Titanium Reinforced d-PTFE Membrane Versus Collagen Membrane For Guided Bone Regeneration
NARecruiting
36 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor3 locations